Canagliflozin Protects Against Liver and Kidney Damage from Acetaminophen in Mice
Author Information
Author(s): Bishr Abeer, El-Mokadem Bassant M., Gomaa Asmaa A.
Primary Institution: Ahram Canadian University
Hypothesis
Canagliflozin can mitigate acetaminophen-induced liver and kidney damage through specific molecular pathways.
Conclusion
Canagliflozin effectively protects against liver and kidney damage caused by acetaminophen overdose in mice.
Supporting Evidence
- Canagliflozin reduced liver enzyme levels significantly in acetaminophen-treated mice.
- Pre-treatment with canagliflozin improved kidney function markers in mice.
- Canagliflozin modulated key signaling pathways involved in oxidative stress and inflammation.
Takeaway
Canagliflozin is a medicine that helps protect the liver and kidneys from damage when too much acetaminophen is taken.
Methodology
Mice were divided into five groups and treated with canagliflozin and acetaminophen, followed by assessments of liver and kidney functions.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
Male ICR mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website